Jan 27 (Reuters) - ‌The ​U.S. ‌Centers for ​Medicare & Medicaid ‍Services on ​Tuesday ​named a ⁠new group of branded drugs ...

In a story common to many an independent oil producer, the company turned a series of huge wildcat discoveries in the 2000s ...

Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing.

AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...

The question was, “What life-changing thing can you buy for less than $100?” These frugal people answered and shared the best ...

The 2026 guidance is what really caught attention. Management expects top-line growth of more than 5% and profit growth in a ...

Fast chargers usually do not damage modern power tool batteries, but heat, poor charging habits, and cheap chargers can ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the cheap S&P 500 stocks to invest in now. On January 12, Bristol-Myers Squibb announced positive topline results from its Phase 3 SCOUT-HCM clinical ...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he ...

On January 8, Nancy Prial, Co-CEO & Senior Portfolio Manager at Essex Investment Management, appeared on CNBC to suggest that she sees big 2026 upside beyond mega-cap tech.

Bristol-Myers Squibb Company (NYSE: BMY) is one of the cheap stocks to buy for the next 3 years. On January 9, Scotiabank analyst Louise Chen raised the firm’s price target on Bristol-Myers to $60 ...